secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zenas BioPharma, Inc. (ZBIO)
CIK:        0001953926
Form:       8-K
Filed at:   2026-02-13T23:59:59+00:00
Accession:  0001104659-26-015314
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zenas BioPharma adopts amended Short-Term Incentive Plan for annual cash bonuses
--------------------------------------------------------------------------------

- Plan effective Jan 1, 2026; provides discretionary annual cash bonuses based on company and individual performance.
- Target awards expressed as percentage of base salary; payouts capped at 150% of target.
- Employees hired after Sep 30 generally ineligible; must be employed through payment date.
- Administered by Board for executives and by CEO/leadership for other employees.
- Company retains right to amend or discontinue plan at any time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1953926/000110465926015314/0001104659-26-015314-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1953926/000110465926015314/tm266357d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-015314

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer